MicroRNA-124 Regulates STAT3 Expression and Is Down-regulated in Colon Tissues of Pediatric Patients With Ulcerative Colitis
Γεώργιος Κούκος(San Francisco VA Medical Center), Dimitrios Iliopoulos(Dana-Farber Cancer Institute), Beatriz Gras-Miralles(Beth Israel Deaconess Medical Center), Jess L. Kaplan(Massachusetts General Hospital), Christos Polytarchou(Dana-Farber Cancer Institute), Alessio Morley-Fletcher(Boston Children's Hospital), Harland S. Winter(Massachusetts General Hospital), Mariah Baril‐Dore(Boston Children's Hospital), Efi Kokkotou(Beth Israel Deaconess Medical Center), Charalabos Pothoulakis(Beth Israel Deaconess Medical Center)
Cited by 232
Related Papers
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
|PLoS ONE|2010|910